α-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction




Petteri Rinne, Wendy Nordlund, Ilkka Heinonen, Anna-Maija Penttinen, Antti Saraste, Suvi T. Ruohonen, Satu Mäkelä, Laura Vähätalo, Katja Kaipio, Minying Cai, Victor J. Hruby, Saku Ruohonen, Eriika Savontaus

PublisherOXFORD UNIV PRESS

2013

Cardiovascular Research

CARDIOVASCULAR RESEARCH

Cardiovasc Res

2

97

2

360

368

9

0008-6363

1755-3245

DOIhttps://doi.org/10.1093/cvr/cvs335



The present study identifies -MSH and endothelial MC1 receptors as a new signalling pathway contributing to the regulation of NO availability and vascular function. These findings suggest applicability of -MSH analogues for therapeutic use in pathological conditions that are characterized by vascular dysfunction.



Last updated on 2024-26-11 at 20:43